Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 47.55% is 138% above its 5-year average of -125.89%, near the high end of its 5-year range (-584.09%–84.42%).
115.95% above its 12-month average of -298.08%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -269.25%.
NET PROFIT MARGIN
47.55%
NET PROFIT MARGIN AVG TTM
-298.08%
NET PROFIT MARGIN AVG 3Y
-192.30%
NET PROFIT MARGIN AVG 5Y
-125.89%
NET PROFIT MARGIN AVG 10Y
-81.86%
NET PROFIT MARGIN AVG 15Y
-84.15%
NET PROFIT MARGIN AVG 20Y
-167.67%
CURRENT VS TTM AVG
+115.95%
CURRENT VS 3Y AVG
+124.73%
CURRENT VS 5Y AVG
+137.77%
CURRENT VS 10Y AVG
+158.09%
CURRENT VS 15Y AVG
+156.51%
CURRENT VS 20Y AVG
+128.36%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 617 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Compugen Ltd.
Market Cap
$213.22M
Net Profit Margin
47.55%
TTM Avg
-298.08%
3Y Avg
-192.30%
5Y Avg
-125.89%
Market Cap
$212.35M
Net Profit Margin
-920285.19%
TTM Avg
-662320.41%
3Y Avg
-376335.80%
5Y Avg
-251721.50%
Market Cap
$214.50M
Net Profit Margin
12.39%
TTM Avg
11.00%
3Y Avg
-1.71%
5Y Avg
-13.45%
Market Cap
$210.39M
Net Profit Margin
-850.13%
TTM Avg
-398.77%
3Y Avg
-257.91%
5Y Avg
-325.14%
Market Cap
$217.70M
Net Profit Margin
74.06%
TTM Avg
51.52%
3Y Avg
44.79%
5Y Avg
47.28%
Market Cap
$202.37M
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$223.58M
Net Profit Margin
-553.88%
TTM Avg
-2620.95%
3Y Avg
-26640.28%
5Y Avg
-17808.90%
Market Cap
$227.52M
Net Profit Margin
-26.97%
TTM Avg
-50.02%
3Y Avg
-94.39%
5Y Avg
-87.59%
Market Cap
$230.02M
Net Profit Margin
-8.70%
TTM Avg
-47.52%
3Y Avg
-47.68%
5Y Avg
-98.44%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compugen Ltd. (CGEN) | $213.22M | 47.55% | -298.08% | -192.30% | -125.89% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $212.35M | -920285.19% | -662320.41% | -376335.80% | -251721.50% |
| Niagen Bioscience Inc (NAGE)vs › | $214.50M | 12.39% | 11.00% | -1.71% | -13.45% |
| Alector, Inc. (ALEC)vs › | $210.39M | -850.13% | -398.77% | -257.91% | -325.14% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $217.70M | 74.06% | 51.52% | 44.79% | 47.28% |
| Electra Therapeutics Inc. (ETRA)vs › | $202.37M | N/A | N/A | N/A | N/A |
| Keros Therapeutics, Inc. (KROS)vs › | $223.58M | -553.88% | -2620.95% | -26640.28% | -17808.90% |
| Biodesix, Inc. (BDSX)vs › | $227.52M | -26.97% | -50.02% | -94.39% | -87.59% |
| MacroGenics, Inc. (MGNX)vs › | $230.02M | -8.70% | -47.52% | -47.68% | -98.44% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $231.35M | -29747.89% | 0.00% | 0.00% | 0.00% |
Operating Margin
40.9%
Net Profit Margin
47.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -269.25% |
| 2026-03-31 | -352.44% |
| 2025-12-31 | 84.42% |
| 2025-09-30 | -369.06% |
| 2025-06-30 | -584.09% |
| 2025-03-31 | -314.40% |
| 2024-12-31 | -415.84% |
| 2024-09-30 | 7.45% |
| 2024-06-30 | -31.68% |
| 2024-03-31 | -283.98% |
| 2023-12-31 | 29.03% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -41.23% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | -102.60% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -428.15% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | -39.88% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 1.04% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | -16022.64% |
| 2016-09-30 | -11115.71% |
| 2016-06-30 | -1337.10% |
| 2016-03-31 | -9248.39% |
| 2015-12-31 | -5.68% |
| 2015-09-30 | -2944.10% |
| 2015-06-30 | -3052.91% |
| 2015-03-31 | -1197.47% |
| 2014-12-31 | -22.62% |
| 2014-09-30 | -314.03% |
| 2014-06-30 | -118.08% |
| 2014-03-31 | -88.98% |
| 2013-12-31 | -164.96% |
| 2013-09-30 | -298.24% |
| 2013-06-30 | -13813.64% |
| 2013-03-31 | -2082.72% |
| 2012-12-31 | -4009.70% |
| 2012-09-30 | -3250.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 1026.42% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | -1060.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | -112.00% |
| 2010-03-31 | -2175.20% |
| 2009-12-31 | -8164.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 1050.67% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | -34336.36% |
| 2008-09-30 | -54800.00% |
| 2008-06-30 | -7417.50% |
| 2008-03-31 | -887.90% |
| 2007-12-31 | -3452.22% |
| 2007-09-30 | -3046.67% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | -38380.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | -72400.00% |
| 2006-03-31 | -1544.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | -466.89% |
| 2005-06-30 | -704.64% |
| 2005-03-31 | -432.14% |
| 2004-12-31 | -678.08% |
| 2004-09-30 | -373.02% |
| 2004-06-30 | -342.17% |
| 2004-03-31 | -196.71% |
| 2003-12-31 | -260.40% |
| 2003-09-30 | -163.63% |
| 2003-06-30 | -80.53% |
| 2003-03-31 | -90.80% |
| 2002-12-31 | -120.77% |
| 2002-09-30 | -107.33% |
